Zhu X G, Park K S, Kaneshige M, Bhat M K, Zhu Q, Mariash C N, McPhie P, Cheng S Y
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mol Cell Biol. 2000 Apr;20(7):2604-18. doi: 10.1128/MCB.20.7.2604-2618.2000.
Thyroid hormone (T3) nuclear receptors (TR) are ligand-dependent transcription factors which regulate growth, differentiation, and development. One emerging hypothesis suggests that TR mediate these diverse effects via a large network of coregulators. Recently, we found that TR-mediated transcriptional responses varied in six cell lines derived from different tissues. We therefore used human TR subtype beta1 (TRbeta1) as bait to search for coregulators in human colon carcinoma RKO cells with a yeast two-hybrid system. RKO cells exhibited T3-dependent and -independent transcriptional activation. One of the three positive clones was identified as Ear-2, which is a distant member of the chick ovalbumin upstream promoter-transcription factors of the orphan nuclear receptor family. The physical interaction between Ear-2 and TRbeta1 was further confirmed by specific binding of Ear-2 to glutathione S-transferase-TRbeta1. In addition, Ear-2 was found to associate with TRbeta1 in cells. As a result of this physical interaction, binding of TRbeta1 to the T3 response elements was inhibited. Using reporter systems, we found that both the basal activation and the T3-dependent activation mediated by TRbeta1 were repressed by Ear-2 in CV1 cells. In RKO cells, however, the T3-independent transcriptional activity was more sensitive to the repression effect of Ear-2 than the T3-dependent transcriptional activity. The repression effect of Ear-2 was reversed by steroid hormone receptor coactivator 1. These results suggest that TR-mediated responses reflect a balance of corepressors and coactivators in cells. These findings further strengthen the hypothesis that the diverse activities of TR are achieved via a large network of coregulators that includes Ear-2.
甲状腺激素(T3)核受体(TR)是依赖配体的转录因子,可调节生长、分化和发育。一种新出现的假说认为,TR通过一个庞大的共调节因子网络介导这些不同的效应。最近,我们发现TR介导的转录反应在源自不同组织的六种细胞系中有所不同。因此,我们用人TR亚型β1(TRbeta1)作为诱饵,利用酵母双杂交系统在人结肠癌细胞RKO中寻找共调节因子。RKO细胞表现出T3依赖性和非依赖性转录激活。三个阳性克隆之一被鉴定为Ear-2,它是孤儿核受体家族的鸡卵清蛋白上游启动子转录因子的远亲成员。Ear-2与谷胱甘肽S-转移酶-TRbeta1的特异性结合进一步证实了Ear-2与TRbeta1之间的物理相互作用。此外,发现Ear-2在细胞中与TRbeta1相关联。这种物理相互作用的结果是,TRbeta1与T3反应元件的结合受到抑制。利用报告系统,我们发现Ear-2在CV1细胞中抑制了TRbeta1介导的基础激活和T3依赖性激活。然而,在RKO细胞中,T3非依赖性转录活性比T3依赖性转录活性对Ear-2的抑制作用更敏感。Ear-2的抑制作用被类固醇激素受体共激活因子1逆转。这些结果表明,TR介导的反应反映了细胞中共抑制因子和共激活因子的平衡。这些发现进一步强化了这样一种假说,即TR的多种活性是通过一个包括Ear-2在内的庞大共调节因子网络实现的。